543897 (4)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE revises price bands for 17 equity scrips with effect from February 26, 2026, with bands ranging from 2% to 20% for companies including … | |||||||||||||||
BSE revises price bands for 17 equity scrips with effect from February 26, 2026, with bands ranging from 2% to 20% for companies including AVI Polymers, Onelife Capital Advisors, and Suryo Foods & Industries.
| |||||||||||||||
BSE revises price bands for 17 equity scrips effective February 26, 2026, with bands set at 2%, 5%, 10%, or 20% under surveillance measures. | |||||||||||||||
BSE revises price bands for 17 equity scrips effective February 26, 2026, with bands set at 2%, 5%, 10%, or 20% under surveillance measures.
| |||||||||||||||
BSE announces updates to the Enhanced Surveillance Measure (ESM) framework effective February 26, 2026, including 3 new securities added, 4 … | |||||||||||||||
BSE announces updates to the Enhanced Surveillance Measure (ESM) framework effective February 26, 2026, including 3 new securities added, 4 moved to higher ESM stages, and none moved to lower stages or removed.
| |||||||||||||||
BSE revises price bands for 8 securities including Aptus Pharma, Colinz Laboratories, Gokak Textiles, and others, effective January 30, … | |||||||||||||||
BSE revises price bands for 8 securities including Aptus Pharma, Colinz Laboratories, Gokak Textiles, and others, effective January 30, 2026.
| |||||||||||||||